These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6626209)

  • 21. Characterization of the calf uterine androgen receptor and its activation to the deoxyribonucleic acid-binding state.
    de Boer W; Lindh M; Bolt J; Brinkmann A; Mulder E
    Endocrinology; 1986 Feb; 118(2):851-61. PubMed ID: 3484700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance hydrophobic interaction chromatography as a means of identifying estrogen receptors expressing different binding domains.
    Hyder SM; Wittliff JL
    J Chromatogr; 1988 Jul; 444():225-37. PubMed ID: 3204133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of gestodene binding to the oestrogen receptor in human malignant breast tissue.
    Iqbal MJ; Colletta AA
    Anticancer Res; 1987; 7(1):45-8. PubMed ID: 3566182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of temperature, nucleotides and sodium molybdate on activation and DNA binding of estrogen, glucocorticoid, progesterone and androgen receptors in MCF-7 human cancer cells.
    Chong MT; Lippman ME
    J Recept Res; 1981-1982; 2(5-6):575-600. PubMed ID: 6296381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the estrogen receptors contained in the MtTF4 tumor whose growth is inhibited by estradiol: 17 beta-estradiol, 17 alpha-estradiol and DNA bindings.
    Albaladejo V; Pharaboz MO; Morel Y; Andre J
    J Steroid Biochem; 1986 Jul; 25(1):29-36. PubMed ID: 3747513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous deoxyribonucleic acid-binding forms of rabbit uterine progesterone receptor.
    Lamb DJ; Bullock DW
    Endocrinology; 1984 May; 114(5):1833-40. PubMed ID: 6714169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of rat liver glucocorticoid receptor by molybdate. Effects on both non-activated and activated receptor complexes.
    Murakami N; Moudgil VK
    Biochem J; 1981 Sep; 198(3):447-55. PubMed ID: 6275847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of molybdate on activation and stabilization of steroid receptors.
    Noma K; Nakao K; Sato B; Nishizawa Y; Matsumoto K; Yamamura Y
    Endocrinology; 1980 Oct; 107(4):1205-11. PubMed ID: 7408768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilisation of the cytoplasmic oestrogen receptor by molybdate.
    Krozowski ZS; Murphy LC
    J Steroid Biochem; 1981 Apr; 14(4):363-6. PubMed ID: 7230798
    [No Abstract]   [Full Text] [Related]  

  • 32. Transformation of human androgen receptors to the deoxyribonucleic acid-binding state.
    Kovacs WJ; Griffin JE; Wilson JD
    Endocrinology; 1983 Nov; 113(5):1574-81. PubMed ID: 6628317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molybdate and the molecular properties of the vervet monkey estrogen receptor.
    Potgieter HC; Klein T; Magagane F; Savage N; Wittliff JL
    J Steroid Biochem; 1986 Dec; 25(6):951-6. PubMed ID: 3795954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human breast tumor estrogen receptor: effects of molybdate and electrophoretic analyses.
    Miller LK; Tuazon FB; Niu EM; Sherman MR
    Endocrinology; 1981 Apr; 108(4):1369-78. PubMed ID: 7472273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal inactivation and molecular forms of the estrogen receptor: effects of molybdate.
    Joab I; Redeuilh G; Secco C; Radanyi C; Baulieu EE; Richard-Foy H
    Biochem Biophys Res Commun; 1981 Nov; 103(2):505-10. PubMed ID: 7332556
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation and immunorecognition by a monoclonal antibody of the tamoxifen-estrogen receptor complex.
    Giambiagi N; Pasqualini JR
    Biochim Biophys Acta; 1986 Oct; 883(3):559-66. PubMed ID: 3756221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement for a reduced sulphydryl entity in the protection of molybdate-stabilized estrogen receptor.
    Ratajczak T; Samec AM; Hähnel R
    FEBS Lett; 1982 Nov; 149(1):80-4. PubMed ID: 7152037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of sodium molybdate on the cytoplasmic estrogen and progesterone receptors in human endometrial tissues.
    Shyamala G; Ferenczy A
    Diagn Gynecol Obstet; 1981; 3(4):277-82. PubMed ID: 7200003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.